85-1437-93 [取扱停止]Sentrin 1, Recombinant, Human (Small Ubiquitin-related Modifier 1, SUMO 1, SMT3C) 10ug S0750-01F
特徴
- Active human SUMO-I (the 1-97 amino acid region of the Ubiquitin-like protein SMT3C precursor also named Ubiquitin-homology domain protein PIC1, Ubiquitin-like protein UBL1, Ubiquitin-related protein SUMO-I, GAP modifying protein-I, GMP-I, and Sentrin-I. Human SUMO-1 (small ubiquitin-like modifier) is an 11kD protein that shares 18% sequence homology with ubiquitin. Smt3p, which is 48% identical to human SUMO-1, has been identified in yeast. SUMO-1/Smt3p is activated by a heterodimeric E1 enzyme in both the yeast and mammalian systems It has been shown that SUMO-1 can be conjugated to a number of proteins such as PML, RanGAP1, I B, FAS/apolipoprotein-1, p53, RAD51 and RAD52.
- Recombinant Human SUMO1 is a single, non-glycosylated, polypeptide chain having a molecular mass of 20kD as seen on SDS-PAGE.
- Endotoxin:≤ 0.1ng/ug (IEU/ug) of ubiquitin-conjugating enzyme
- Storage and Stability:May be stored at 4°C for short-term only. For long-term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Aliquot and store at -20°C. Aliquots are stable for at least 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
仕様
- Size:10ug
- Source Antigen:Recombinant, E. coli
- Grade:Highly Purified
- Purity:≥ 95% by RP-HPLC, FPLC, or reducing/non-reducing SDS-PAGE Silver Stain. Chromatographically purified.
- Form:Supplied as a lyophilized powder. No additives.
- EU Commodity Code:30021019
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]
商品のバリエーション (サイズ違い・スペック違い・オプション品など)
よくあるご質問(FAQ)
掲載カタログ情報
| 掲載カタログ名 | 掲載ページ |
|---|





